Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency Post author: Post published:March 25, 2026 Post category: Continue ReadingClinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency
Stem Cell Gene Therapy for Sickle Cell Disease Post author: Post published:March 25, 2026 Post category: Continue ReadingStem Cell Gene Therapy for Sickle Cell Disease
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer Post author: Post published:March 25, 2026 Post category: Continue ReadingCCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) Post author: Post published:March 25, 2026 Post category: Continue ReadingPhase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma Post author: Post published:March 25, 2026 Post category: Continue ReadingPembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Post author: Post published:March 18, 2026 Post category: Continue ReadingKidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia Post author: Post published:March 17, 2026 Post category: Continue ReadingA Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma Post author: Post published:March 17, 2026 Post category: Continue ReadingA Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma Post author: Post published:March 17, 2026 Post category: Continue ReadingBrain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
A Phase 1/2 Trial of ADI-270 in ccRCC Post author: Post published:March 17, 2026 Post category: Continue ReadingA Phase 1/2 Trial of ADI-270 in ccRCC
